Company Selected - Takeda Pharmaceutical Co. Ltd. - Solvency
| Fiscal Year is From April To March | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | View Chart |
|---|---|---|---|---|---|
| Debt To Assets Ratio | 32.10% | 32.17% | 32.14% | 32.04% | |
| Equity To Assets Ratio | 49.29% | 49.03% | 48.68% | 49.11% | |
| Debt To Capital Ratio | 39.45% | 39.63% | 39.77% | 39.48% | |
| Debt To Equity Ratio | 0.6515x | 0.6563x | 0.6604x | 0.6525x | |
| Financial Leverage Ratio | 2.04x | 2.06x | 2.07x | 2.07x | |
| EBIT Interest Coverage | 1.37x | 1.75x | 1.85x | 2.13x | |
| EBITDA Interest Coverage | 4.18x | 4.66x | 5.48x | 5.80x | |
| Funds From Operation To Total Debt | 24.24% | 22.35% | 21.02% | 21.56% | |
| Total Debt To EBITDA | 4.09x | 3.75x | 3.98x | 4.03x | |
| Altman Z-Score | 1.09 | 1.14 | 1.13 | 1.05 |